Mioara-Laura Macovei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mioara-Laura Macovei has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Adrian Marinescu
*“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
1 shared publication- Alexandra-Georgiana Vîrlan
Pediatric Neurology Department, “Prof. Dr. Alexandru Obregia” Clinical Psychiatric Hospital, 041914 Bucharest, Romania
1 shared publication - Alina Gabriela Gheorghe
Department of Ophthalmology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
1 shared publication - Andreea Alexandra Mihaela Musat
Doctoral School, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania
1 shared publication - Andreea Pleșa
Doctoral School, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
1 shared publication - Any Docu Axelerad
Department of Neurology, General Medicine Faculty, “Ovidius” University, 900470 Constanta, Romania
1 shared publication
Latest Publications
- Open Access
- 17 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3380
Artificial Intelligence Applications in Laser-Assisted Refractive Surgery—A Comprehensive Review
Background/Objectives: Artificial Intelligence (AI) technology—in the form of Machine Learning (ML) models and other models specialized in image recognition and processing, such as Convolutional Neural Networks Visual Transformers (CNN-ViTs)—is increasingly being used in ophthalmology. This review summarizes the main AI applications for laser-assisted refractive surgery. Methods: A wide-ranging literature search on the PubMed and ISI Thompson Web of Science databases was conducted. Results: AI is an all-encompassing technological concept that refers to either specific applications of ML/CNN models, such as in keratoconus screening or diagnosis, or agentic/multimodal AI applications that process different data types using a variety of AI models. The most clinically established applications found were corneal ectasia and keratoconus screening, in which AI models can reliably exceed 95% diagnostic accuracy, specificity, and sensitivity; nomogram-derived laser ablation programming; optimization of ray-tracing calculations for ray-traced ablation profiles; patient screening and selection for refractive surgery; visual and refractive result prediction; assessment of postoperative corneal ectasia risk; detection of intraoperative complications; research on the laser coupling effect; and other applications such as monitoring eye rubbing behavior in corneal ectasia suspects. Thus, singular, specific applications of AI models have made the largest clinical contributions. These results must be interpreted with a comparison of internal versus external validation, calibration, and generalizability. Overall the technology is highly promising. Agentic/multimodal AI frameworks are currently being discussed, with pilot studies published and applicability proposed in the context of large, high-patient-volume clinical practices. The technological advent of SHAP force plot graphs and saliency maps has improved understanding of the factors that contribute mechanistically to AI model reasoning, leading to more informed clinical decisions or research applicability, such as in finding parameters or factors linked to postoperative ectasia. Conclusions: AI is already established in laser-assisted refractive surgery in the form of models specialized in data-intensive analysis. At present, the best-performing novel AI models originate from the domain of large or multi-hospital settings due to requirements for multiple latest-generation diagnostic devices, high-volume patient data, computing expertise, and resources. Future directions could include clinical standardization and trickle-down dissemination of the technology. Agentic/multimodal AI has the potential to benefit large clinical/patient settings or offer access to expert knowledge in smaller practice settings. Agentic/multimodal AI implementation is offset by challenges in complexity, the technological limitations of LLMs (“hallucinations”), and ethical and legislative factors.
- 17 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3380
Open AccessArtificial Intelligence Applications in Laser-Assisted Refractive Surgery—A Comprehensive Review
Background/Objectives: Artificial Intelligence (AI) technology—in the form of Machine Learning (ML) models and other models specialized in image recognition and processing, such as Convolutional Neural Networks Visual Transformers (CNN-ViTs)—is increasingly being used in ophthalmology. This review summarizes the main AI applications for laser-assisted refractive surgery. Methods: A wide-ranging literature search on the PubMed and ISI Thompson Web of Science databases was conducted. Results: AI is an all-encompassing technological concept that refers to either specific applications of ML/CNN models, such as in keratoconus screening or diagnosis, or agentic/multimodal AI applications that process different data types using a variety of AI models. The most clinically established applications found were corneal ectasia and keratoconus screening, in which AI models can reliably exceed 95% diagnostic accuracy, specificity, and sensitivity; nomogram-derived laser ablation programming; optimization of ray-tracing calculations for ray-traced ablation profiles; patient screening and selection for refractive surgery; visual and refractive result prediction; assessment of postoperative corneal ectasia risk; detection of intraoperative complications; research on the laser coupling effect; and other applications such as monitoring eye rubbing behavior in corneal ectasia suspects. Thus, singular, specific applications of AI models have made the largest clinical contributions. These results must be interpreted with a comparison of internal versus external validation, calibration, and generalizability. Overall the technology is highly promising. Agentic/multimodal AI frameworks are currently being discussed, with pilot studies published and applicability proposed in the context of large, high-patient-volume clinical practices. The technological advent of SHAP force plot graphs and saliency maps has improved understanding of the factors that contribute mechanistically to AI model reasoning, leading to more informed clinical decisions or research applicability, such as in finding parameters or factors linked to postoperative ectasia. Conclusions: AI is already established in laser-assisted refractive surgery in the form of models specialized in data-intensive analysis. At present, the best-performing novel AI models originate from the domain of large or multi-hospital settings due to requirements for multiple latest-generation diagnostic devices, high-volume patient data, computing expertise, and resources. Future directions could include clinical standardization and trickle-down dissemination of the technology. Agentic/multimodal AI has the potential to benefit large clinical/patient settings or offer access to expert knowledge in smaller practice settings. Agentic/multimodal AI implementation is offset by challenges in complexity, the technological limitations of LLMs (“hallucinations”), and ethical and legislative factors.
- Open Access
- 7 February 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (4) , 402
The Perspective of Using Optical Coherence Tomography in Ophthalmology: Present and Future Applications
Optical coherence tomography (OCT) imaging plays a major role in the field of diagnosing, monitoring, and treating ophthalmological diseases. Since its introduction in the early 1990s, OCT technology has continued to advance both in the direction of acquisition quality and technique. In this manuscript, we concentrate on actual and future applications of OCT in the ophthalmology field, reviewing multiple types of OCT techniques and systems, such as visible-light OCT, adaptative optics OCT, intraoperative OCT, wide-field OCT, and more. All of them allow better monitoring of ocular diseases, earlier and broader diagnosis, and a more suitable treatment. Furthermore, overviewing all these technologies could play a pivotal role in research, leading to an advance in understanding the pathophysiology of targeted diseases. Finally, the aim of the present review was to evaluate the technical advances in OCT and their actual and potential clinical applications.
- 7 February 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (4) , 402
Open AccessThe Perspective of Using Optical Coherence Tomography in Ophthalmology: Present and Future Applications
Optical coherence tomography (OCT) imaging plays a major role in the field of diagnosing, monitoring, and treating ophthalmological diseases. Since its introduction in the early 1990s, OCT technology has continued to advance both in the direction of acquisition quality and technique. In this manuscript, we concentrate on actual and future applications of OCT in the ophthalmology field, reviewing multiple types of OCT techniques and systems, such as visible-light OCT, adaptative optics OCT, intraoperative OCT, wide-field OCT, and more. All of them allow better monitoring of ocular diseases, earlier and broader diagnosis, and a more suitable treatment. Furthermore, overviewing all these technologies could play a pivotal role in research, leading to an advance in understanding the pathophysiology of targeted diseases. Finally, the aim of the present review was to evaluate the technical advances in OCT and their actual and potential clinical applications.
- Open Access
- 2 October 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (19) , 2198
Eyes as Windows: Unveiling Neuroinflammation in Multiple Sclerosis via Optic Neuritis and Uhthoff’s Phenomenon
Background/Objectives: This study investigated the frequency and timing of optic neuritis (ON) episodes in relation to the onset of multiple sclerosis (MS) and examined the occurrence of Uhthoff’s phenomenon and Lhermitte’s sign to understand their roles in early diagnosis and disease progression. Methods: A longitudinal study was conducted with 127 MS patients. Clinical data, including ophthalmological examinations for ON, were collected and questionnaires assessed the presence of Uhthoff’s phenomenon and Lhermitte’s sign. Results: Results showed that 37% of patients experienced demyelinating retrobulbar ON, with 25.53% having ON as the initial symptom of MS. Residual visual acuity impairment (below 20/40) and dyschromatopsia were reported by 25.53% and 17.02% of patients, respectively. Uhthoff’s phenomenon and Lhermitte’s sign were present in 26.77% and 36.22% of patients, respectively. The findings underscore the importance of early ophthalmological assessments in diagnosing MS, as ON can be an initial indicator of the disease. Conclusions: The study highlights the need for precise diagnostic tools and personalized therapeutic strategies focused on specific biomarkers and pathways involved in neuroinflammation and demyelination. Early diagnosis through vigilant ophthalmologic evaluation can lead to interventions that significantly alter disease progression, improving patient outcomes and quality of life.
- 2 October 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (19) , 2198
Open AccessEyes as Windows: Unveiling Neuroinflammation in Multiple Sclerosis via Optic Neuritis and Uhthoff’s Phenomenon
Background/Objectives: This study investigated the frequency and timing of optic neuritis (ON) episodes in relation to the onset of multiple sclerosis (MS) and examined the occurrence of Uhthoff’s phenomenon and Lhermitte’s sign to understand their roles in early diagnosis and disease progression. Methods: A longitudinal study was conducted with 127 MS patients. Clinical data, including ophthalmological examinations for ON, were collected and questionnaires assessed the presence of Uhthoff’s phenomenon and Lhermitte’s sign. Results: Results showed that 37% of patients experienced demyelinating retrobulbar ON, with 25.53% having ON as the initial symptom of MS. Residual visual acuity impairment (below 20/40) and dyschromatopsia were reported by 25.53% and 17.02% of patients, respectively. Uhthoff’s phenomenon and Lhermitte’s sign were present in 26.77% and 36.22% of patients, respectively. The findings underscore the importance of early ophthalmological assessments in diagnosing MS, as ON can be an initial indicator of the disease. Conclusions: The study highlights the need for precise diagnostic tools and personalized therapeutic strategies focused on specific biomarkers and pathways involved in neuroinflammation and demyelination. Early diagnosis through vigilant ophthalmologic evaluation can lead to interventions that significantly alter disease progression, improving patient outcomes and quality of life.
- Open Access
- 6 July 2024
- Published by Societatea Romana de Oftalmologie in Romanian Journal of Ophthalmology
- Vol. 68 (2) , 152-157
Ocular involvement in highly treatment-experienced patients with HIV
Introduction: Ocular involvement in human immunodeficiency virus (HIV) infected and treatment-experienced patients is a significant concern, despite the advancements in antiretroviral therapy (ART) medication. The extended life expectancy of HIV patients has altered the spectrum of HIV-associated ocular diseases, ranging from minor issues to severe vision impairment or blindness. Therefore, understanding these complications becomes crucial in providing comprehensive medical care and quality of life improvement. HIV patients on multiple ARTs can experience various ocular disorders due to the complexity of their treatment regimens, drug toxicities, immune reconstitution, and opportunistic infections. Most worthy to consider are: cytomegalovirus (CMV) retinitis, immune recovery uveitis (IRU), keratoconjunctivitis sicca (dry eye syndrome), and HIV-associated neuroretinal disorders.
- 6 July 2024
- Published by Societatea Romana de Oftalmologie in Romanian Journal of Ophthalmology
- Vol. 68 (2) , 152-157
Open AccessOcular involvement in highly treatment-experienced patients with HIV
Introduction: Ocular involvement in human immunodeficiency virus (HIV) infected and treatment-experienced patients is a significant concern, despite the advancements in antiretroviral therapy (ART) medication. The extended life expectancy of HIV patients has altered the spectrum of HIV-associated ocular diseases, ranging from minor issues to severe vision impairment or blindness. Therefore, understanding these complications becomes crucial in providing comprehensive medical care and quality of life improvement. HIV patients on multiple ARTs can experience various ocular disorders due to the complexity of their treatment regimens, drug toxicities, immune reconstitution, and opportunistic infections. Most worthy to consider are: cytomegalovirus (CMV) retinitis, immune recovery uveitis (IRU), keratoconjunctivitis sicca (dry eye syndrome), and HIV-associated neuroretinal disorders.
- Open Access
- 20 July 2022
- Published by Fundatia Universitara Sanabuna in Romanian Journal of Ophthalmology
- Vol. 66 (2) , 153-157
A case report of a patient with severe thyroid eye disease
Objective: Our aim was to present a rare case of a middle-aged male patient, diagnosed with Graves' orbitopathy, which had an atypical rapid unilateral onset. Initially, the left eye presented exophthalmos, eyelid retraction, corneal ulceration, and pannus formation with an important vascular component due to corneal exposure. The same symptoms developed in the right eye within a short period of time. Methods: A 52-year-old man presented in our department with bilateral proptosis, decrease in visual acuity, and orbital pain, which developed initially in the left eye seven months before the right eye. Slit lamp examination revealed conjunctival hyperemia, purulent discharge, chemosis and inflammation of the caruncle in both eyes. The fluorescein eye stain test was positive due to corneal ulceration with the presence of cells and flare in anterior chamber in the RE (right eye). The LE (left eye) presented a corneal pannus. We documented the changes using a slit lamp biomicroscope, a fundus camera, orbital ultrasonography, and contrast CT (computer tomography) scans. Discussions: The severe Graves' ophthalmopathy represents a challenge both in active or inactive phase. Medical and surgical therapies should be taken into consideration in order to prevent the complications following corneal perforation or optic neuropathy. Also, ophthalmic, and systemic adverse reactions of systemic steroids used in the treatment of Graves' disease are important in the prognosis of the visual outcome. Conclusions: The management of Graves' ophthalmopathy is multidisciplinary and needs a very good therapy adherence in order to achieve a satisfactory prognosis and quality of life.
- 20 July 2022
- Published by Fundatia Universitara Sanabuna in Romanian Journal of Ophthalmology
- Vol. 66 (2) , 153-157
Open AccessA case report of a patient with severe thyroid eye disease
Objective: Our aim was to present a rare case of a middle-aged male patient, diagnosed with Graves' orbitopathy, which had an atypical rapid unilateral onset. Initially, the left eye presented exophthalmos, eyelid retraction, corneal ulceration, and pannus formation with an important vascular component due to corneal exposure. The same symptoms developed in the right eye within a short period of time. Methods: A 52-year-old man presented in our department with bilateral proptosis, decrease in visual acuity, and orbital pain, which developed initially in the left eye seven months before the right eye. Slit lamp examination revealed conjunctival hyperemia, purulent discharge, chemosis and inflammation of the caruncle in both eyes. The fluorescein eye stain test was positive due to corneal ulceration with the presence of cells and flare in anterior chamber in the RE (right eye). The LE (left eye) presented a corneal pannus. We documented the changes using a slit lamp biomicroscope, a fundus camera, orbital ultrasonography, and contrast CT (computer tomography) scans. Discussions: The severe Graves' ophthalmopathy represents a challenge both in active or inactive phase. Medical and surgical therapies should be taken into consideration in order to prevent the complications following corneal perforation or optic neuropathy. Also, ophthalmic, and systemic adverse reactions of systemic steroids used in the treatment of Graves' disease are important in the prognosis of the visual outcome. Conclusions: The management of Graves' ophthalmopathy is multidisciplinary and needs a very good therapy adherence in order to achieve a satisfactory prognosis and quality of life.
- Open Access
- 19 January 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (2) , 234
Intraocular Pressure Measurement after Penetrating Keratoplasty
Assessing the intraocular pressure is a difficult but crucial task in the follow-up of patients that have undergone penetrating keratoplasty. Early recognition of elevated intraocular pressure and/or glaucoma and establishment of the appropriate treatment is essential to ensure the best possible visual outcome for patients dealing with this feared complication. Although Goldmann applanation tonometry is still the gold standard for measuring the intraocular pressure, its limitations in postkeratoplasty eyes, due to postoperative modified corneal morphology, have led to the search for more suitable alternatives. This review is the result of a comprehensive literature search in the MEDLINE database that aims to present glaucoma in the context of perforating keratoplasty, the corneal properties with impact on ocular pressure measurement, and the results achieved with the most important tonometers that have been studied in this pathology. Goldmann applanation tonometry remains the reference for intraocular pressure assessment even in corneas after penetrating keratoplasty. However, some promising alternatives have emerged, the most important of which are the Pascal dynamic contour tonometry, the Tono-Pen XL, the ocular response analyzer, and the iCare. All have advantages and disadvantages but have proved to be appropriate alternatives, especially in cases in which Goldmann applanation tonometry cannot be used.
- 19 January 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (2) , 234
Open AccessIntraocular Pressure Measurement after Penetrating Keratoplasty
Assessing the intraocular pressure is a difficult but crucial task in the follow-up of patients that have undergone penetrating keratoplasty. Early recognition of elevated intraocular pressure and/or glaucoma and establishment of the appropriate treatment is essential to ensure the best possible visual outcome for patients dealing with this feared complication. Although Goldmann applanation tonometry is still the gold standard for measuring the intraocular pressure, its limitations in postkeratoplasty eyes, due to postoperative modified corneal morphology, have led to the search for more suitable alternatives. This review is the result of a comprehensive literature search in the MEDLINE database that aims to present glaucoma in the context of perforating keratoplasty, the corneal properties with impact on ocular pressure measurement, and the results achieved with the most important tonometers that have been studied in this pathology. Goldmann applanation tonometry remains the reference for intraocular pressure assessment even in corneas after penetrating keratoplasty. However, some promising alternatives have emerged, the most important of which are the Pascal dynamic contour tonometry, the Tono-Pen XL, the ocular response analyzer, and the iCare. All have advantages and disadvantages but have proved to be appropriate alternatives, especially in cases in which Goldmann applanation tonometry cannot be used.
- Open Access
- 1 January 2017
- Published by Fundatia Universitara Sanabuna in Romanian Journal of Ophthalmology
- Vol. 61 (4) , 299-305
Endothelial keratoplasty for Fuchs dystrophy
We report the case of a 69-year-old female with Fuchs endothelial dystrophy and posterior chamber in-the-bag intraocular lens, whom we treated with DMEK surgical technique. We encountered difficulties both during obtaining the endothelium from the young donor and during the intraocular unrolling and its application on the stroma. We evaluated both preoperative and postoperative the following parameters: visual acuity, slit lamp, and optical coherence tomography appearance of the cornea, corneal thickness, intraocular pressure, endothelial cell density. In all postoperative assessments, the endothelium was attached to the host's stroma, with small peripheral, inferior folding area. Short-term results were favorable with a clear cornea and significant improvement in visual acuity obtained in the first 3 months of postoperative follow-up. Abbreviation: BCVA = best-corrected visual acuity, RE = right eye, LE = left eye, OCT = optical coherence tomography, DMEK = Descemet membrane endothelial keratoplasty.
- 1 January 2017
- Published by Fundatia Universitara Sanabuna in Romanian Journal of Ophthalmology
- Vol. 61 (4) , 299-305
Open AccessEndothelial keratoplasty for Fuchs dystrophy
We report the case of a 69-year-old female with Fuchs endothelial dystrophy and posterior chamber in-the-bag intraocular lens, whom we treated with DMEK surgical technique. We encountered difficulties both during obtaining the endothelium from the young donor and during the intraocular unrolling and its application on the stroma. We evaluated both preoperative and postoperative the following parameters: visual acuity, slit lamp, and optical coherence tomography appearance of the cornea, corneal thickness, intraocular pressure, endothelial cell density. In all postoperative assessments, the endothelium was attached to the host's stroma, with small peripheral, inferior folding area. Short-term results were favorable with a clear cornea and significant improvement in visual acuity obtained in the first 3 months of postoperative follow-up. Abbreviation: BCVA = best-corrected visual acuity, RE = right eye, LE = left eye, OCT = optical coherence tomography, DMEK = Descemet membrane endothelial keratoplasty.